文献速递乳房整形与再造美容整形

POLYtxt与MESMO乳房假体晚期血清肿及并发症的单术者回顾性比较

Preliminary outcomes and comparison of polytech POLYtxtⓇ and MESMOsensitiveⓇ breast implants with focus on late seroma: Single-surgeon, retrospective cohort study on 621 consecutive aesthetic breast surgery cases.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-01-11

单术者回顾性分析621例初次美容隆乳或隆乳加乳房固定术患者,POLYtxt组358例、MESMO组263例。两组血肿、感染、早期血清肿、包膜挛缩及移位/旋转发生率相当,但晚期血清肿发生率分别为6.4%与0%,总体并发症(12.5% vs 4.5%)与再干预率(9.2% vs 3.8%)MESMO组显著更低。

要点

  • POLYtxt组晚期血清肿发生率为6.4%,MESMO组为0%,差异有统计学意义。
  • MESMO组总体并发症12.5% vs 4.5%、再干预9.2% vs 3.8%,均显著低于POLYtxt组。
  • 血肿、感染、早期血清肿、包膜挛缩及移位/旋转两组发生率相当。

核心结论

  • 与MESMO表面假体相比,POLYtxt表面假体总体并发症与再手术风险更高。
  • 使用纹理更激进的POLYtxt时晚期血清肿发生率异常高,而MESMO不良事件发生率显著低,已成为该术者日常首选。

研究设计与样本

  • 单术者回顾性队列研究,纳入2015年1月至2018年9月621例初次美容乳房手术(隆乳或隆乳加乳房固定术)患者。
  • POLYtxt组358例,MESMO Sensitive组263例,均使用Polytech微纹理硅胶假体,按表面纹理类型比较并发症,主要关注晚期血清肿。

主要发现

  • 血肿、感染、早期血清肿、包膜挛缩及移位/旋转发生率两组相当。
  • 晚期血清肿发生率POLYtxt组6.4%、MESMO组0%,两组差异有统计学意义。
  • 总体并发症POLYtxt组12.5%、MESMO组4.5%,再干预POLYtxt组9.2%、MESMO组3.8%,MESMO组显著更低。

临床怎么用

  • 选择乳房假体表面纹理时,应将晚期血清肿及总体并发症风险纳入知情同意与假体选择讨论。
  • 对使用POLYtxt等较激进纹理假体的患者,建议加强晚期血清肿的随访监测。

局限性

  • 本研究为单术者回顾性队列研究,证据等级有限。
  • 随访约3年,属初步结果,长期交互作用仍需更长期、低偏倚的比较研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent history shows incomplete understanding of the long-term interaction between breast implants and biological tissues. Although complications of silicone-textured implants have been previously reported, conclusive data are still controversial due to the lack of reduced bias, long-term, comparative studies. We present our preliminary outcomes of 3 years aesthetic use of POLYTECH silicone POLYtxtⓇ and MESMO SensitiveⓇ implants. METHODS: This article is a retrospective analysis of 621 patients who have undergone primary aesthetic breast surgery (breast augmentation (BA) or augmentation mastopexy). The surgeries were performed by a single surgeon using Polytech microtextured silicone implants (POLYtxt and MESMO). Complications, with main focus on late seroma, were assessed and compared based on texturization type. RESULTS: From January 2015 to September 2018, 358 patients were treated with POLYtxt and 263 with MESMO-textured implants. Incidence of complications, such as hematoma, infection, early seroma, capsular contraction and malposition/rotation was comparable between the two groups. Incidence of late seroma was, respectively, 6.4% (POLYtxt) and 0% (MESMO) resulting in a statistically significant difference between the two groups. Overall complications and reinterventions were 12.5%-9.2% (POLYtxt) and 4.5%-3.8% (MESMO), respectively, showing a significantly lower occurrence in the MESMO group. CONCLUSIONS: This reduced bias study shows an increased risk in overall complications and reoperations with POLYtxt surface implants compared with MESMO. Furthermore, we registered an exceptionally high rate of late seroma when the more "aggressive" POLYtxt texturization was used. Conversely, a significantly low incidence of adverse events was registered with the MESMO surface, which has turned this device in our first choice in daily practice.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Marcelli S, Aso J. Preliminary outcomes and comparison of polytech POLYtxtⓇ and MESMOsensitiveⓇ breast implants with focus on late seroma: Single-surgeon, retrospective cohort study on 621 consecutive aesthetic breast surgery cases. J Plast Reconstr Aesthet Surg. 2021. PMID: 33582050. doi:10.1016/j.bjps.2020.12.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。